Joss-stick moxibustion reduces inflammatory response of acute eczema by inhibiting IL-6/STAT3 signaling, and balancing Th17/Treg to normalize filaggrin and Caspase-14 levels in rats
|更新时间:2025-06-21
|
Joss-stick moxibustion reduces inflammatory response of acute eczema by inhibiting IL-6/STAT3 signaling, and balancing Th17/Treg to normalize filaggrin and Caspase-14 levels in rats
“The latest research has found that moxibustion therapy can alleviate the inflammatory response of acute eczema rats by regulating the IL-6/STAT3 pathway, promote the recovery of Th17/Treg balance, and normalize FLG and Caspase-14 levels.”
LI Xin-ying,ZHAO Ying-ying,LI Zhi-jie,et al.Joss-stick moxibustion reduces inflammatory response of acute eczema by inhibiting IL-6/STAT3 signaling, and balancing Th17/Treg to normalize filaggrin and Caspase-14 levels in rats[J].Acupuncture Research,2025,50(03):295-301.
LI Xin-ying,ZHAO Ying-ying,LI Zhi-jie,et al.Joss-stick moxibustion reduces inflammatory response of acute eczema by inhibiting IL-6/STAT3 signaling, and balancing Th17/Treg to normalize filaggrin and Caspase-14 levels in rats[J].Acupuncture Research,2025,50(03):295-301. DOI: 10.13702/j.1000-0607.20231124.
Joss-stick moxibustion reduces inflammatory response of acute eczema by inhibiting IL-6/STAT3 signaling, and balancing Th17/Treg to normalize filaggrin and Caspase-14 levels in rats